These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23026689)

  • 1. The potential economic value of a human norovirus vaccine for the United States.
    Bartsch SM; Lopman BA; Hall AJ; Parashar UD; Lee BY
    Vaccine; 2012 Nov; 30(49):7097-104. PubMed ID: 23026689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of norovirus vaccination in children in Peru.
    Mirelman AJ; Ballard SB; Saito M; Kosek MN; Gilman RH
    Vaccine; 2015 Jun; 33(27):3084-91. PubMed ID: 25980428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic challenges in norovirus vaccine development.
    Hallowell BD; Parashar UD; Hall AJ
    Hum Vaccin Immunother; 2019; 15(6):1279-1283. PubMed ID: 30481104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of immunity to norovirus gastroenteritis.
    Simmons K; Gambhir M; Leon J; Lopman B
    Emerg Infect Dis; 2013 Aug; 19(8):1260-7. PubMed ID: 23876612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norovirus vaccine development: next steps.
    Atmar RL; Estes MK
    Expert Rev Vaccines; 2012 Sep; 11(9):1023-5. PubMed ID: 23151158
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling norovirus transmission and vaccination.
    Gaythorpe KAM; Trotter CL; Conlan AJK
    Vaccine; 2018 Sep; 36(37):5565-5571. PubMed ID: 30076105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the global burden of noroviruses and opportunities for prevention.
    Hall AJ; Glass RI; Parashar UD
    Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965
    [No Abstract]   [Full Text] [Related]  

  • 8. A norovirus vaccine on the horizon?
    Vinjé J
    J Infect Dis; 2010 Dec; 202(11):1623-5. PubMed ID: 20979457
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-assessing the total burden of norovirus circulating in the United Kingdom population.
    Harris JP; Iturriza-Gomara M; O'Brien SJ
    Vaccine; 2017 Feb; 35(6):853-855. PubMed ID: 28094075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of acute gastroenteritis, norovirus and rotavirus in a managed care population.
    Karve S; Krishnarajah G; Korsnes JS; Cassidy A; Candrilli SD
    Hum Vaccin Immunother; 2014; 10(6):1544-56. PubMed ID: 24732307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control.
    Lopman BA; Steele D; Kirkwood CD; Parashar UD
    PLoS Med; 2016 Apr; 13(4):e1001999. PubMed ID: 27115709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.
    Aliabadi N; Lopman BA; Parashar UD; Hall AJ
    Expert Rev Vaccines; 2015; 14(9):1241-53. PubMed ID: 26224658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global age distribution of pediatric norovirus cases.
    Shioda K; Kambhampati A; Hall AJ; Lopman BA
    Vaccine; 2015 Aug; 33(33):4065-8. PubMed ID: 26051514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.
    Bernstein DI; Atmar RL; Lyon GM; Treanor JJ; Chen WH; Jiang X; Vinjé J; Gregoricus N; Frenck RW; Moe CL; Al-Ibrahim MS; Barrett J; Ferreira J; Estes MK; Graham DY; Goodwin R; Borkowski A; Clemens R; Mendelman PM
    J Infect Dis; 2015 Mar; 211(6):870-8. PubMed ID: 25210140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of children with norovirus disease in rotavirus vaccine era.
    Wikswo ME; Desai R; Edwards KM; Staat MA; Szilagyi PG; Weinberg GA; Curns AT; Lopman B; Vinjé J; Parashar UD; Payne DC; Hall AJ
    Emerg Infect Dis; 2013 Oct; 19(10):1691-3. PubMed ID: 24047618
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine against norovirus.
    Tan M; Jiang X
    Hum Vaccin Immunother; 2014; 10(6):1449-56. PubMed ID: 24718366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norovirus vaccine: one step closer.
    Vesikari T; Blazevic V
    J Infect Dis; 2015 Mar; 211(6):853-5. PubMed ID: 25210142
    [No Abstract]   [Full Text] [Related]  

  • 18. Norovirus: Facts and Reflections from Past, Present, and Future.
    Lucero Y; Matson DO; Ashkenazi S; George S; O'Ryan M
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Economic Burden of Norovirus Gastroenteritis.
    Bartsch SM; Lopman BA; Ozawa S; Hall AJ; Lee BY
    PLoS One; 2016; 11(4):e0151219. PubMed ID: 27115736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norovirus Vaccine: Priorities for Future Research and Development.
    Esposito S; Principi N
    Front Immunol; 2020; 11():1383. PubMed ID: 32733458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.